Oncotarget

Vol 9, No 34

May 4, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 34 of Oncotarget features Figure 2, "Potential paradigm-shifting effect of a cancer stem cell (CSC) inhibitor on tumor chemoresistance," from Oronsky, et al.

Table of Contents

Research Papers

Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression

Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression

https://doi.org/10.18632/oncotarget.24157

Jie Wang, Han Cai, Yue Xia, Shiying Wang, Likai Xing, Chao Chen, Yong Zhang, Jie Xu, Peihao Yin, Yiming Jiang, Ronghua Zhao, Qingshong Zuo,  and Teng Chen
23320-23333
Abstract  |  PDF  |  HTML  |  Order a Reprint

The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells

The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells

https://doi.org/10.18632/oncotarget.25101

Sabrina D’Agostino, Delia Lanzillotta, Mariaconcetta Varano, Cirino Botta, Antonio Baldrini, Anna Bilotta, Stefania Scalise, Vincenzo Dattilo, Rosario Amato, Eugenio Gaudio, Francesco Paduano, Camillo Palmieri, Rodolfo Iuliano, Nicola Perrotti, Cesare Indiveri, Alfredo Fusco, Marco Gaspari,  and Francesco Trapasso
23334-23348
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The multifunctional protein YB-1 potentiates PARP1 activity and decreases the efficiency of PARP1 inhibitors

The multifunctional protein YB-1 potentiates PARP1 activity and decreases the efficiency of PARP1 inhibitors

https://doi.org/10.18632/oncotarget.25158

Elizaveta E. Alemasova, Konstantin N. Naumenko, Tatyana A. Kurgina, Rashid O. Anarbaev,  and Olga I. Lavrik
23349-23365
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinoma

Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinoma

https://doi.org/10.18632/oncotarget.25163

Richard Kim, Domenico Coppola, Emilie Wang, Young Doo Chang, Yuhree Kim, Daniel Anaya,  and Dae Won Kim
23366-23372
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors

Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors

https://doi.org/10.18632/oncotarget.25169

María Rodríguez-Muñoz, Pilar Sánchez-Blázquez,  and Javier Garzón
23373-23389
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Pilot study of dovitinib in patients with von Hippel-Lindau disease

Pilot study of dovitinib in patients with von Hippel-Lindau disease

https://doi.org/10.18632/oncotarget.25171

Patrick Pilié, Elshad Hasanov, Surena F. Matin, Ashley H. Henriksen Woodson, Valerie D. Marcott, Shelly Bird, Rebecca S. Slack, Gregory N. Fuller, Ian E. McCutcheon,  and Eric Jonasch
23390-23395
Abstract  |  PDF  |  HTML  |  Order a Reprint

Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells

Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells

https://doi.org/10.18632/oncotarget.25174

Eliana Noelia Alonso, María Julia Ferronato, María Eugenia Fermento, Norberto Ariel Gandini, Alejandro López Romero, Josefina Alejandra Guevara, María Marta Facchinetti,  and Alejandro Carlos Curino
23396-23412
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2

A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2

https://doi.org/10.18632/oncotarget.25182

Marine Daures, Mouhamed Idrissou, Gaëlle Judes, Khaldoun Rifaï, Frédérique Penault-Llorca, Yves-Jean Bignon, Laurent Guy,  and Dominique Bernard-Gallon
23413-23425
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity

Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity

https://doi.org/10.18632/oncotarget.25193

Jacopo Junio Valerio Branca, Mario Maresca, Gabriele Morucci, Matteo Becatti, Ferdinando Paternostro, Massimo Gulisano, Carla Ghelardini, Daniela Salvemini, Lorenzo Di Cesare Mannelli,  and Alessandra Pacini
23426-23438
Abstract  |  PDF  |  HTML  |  Order a Reprint

Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells

Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells

https://doi.org/10.18632/oncotarget.25211

Bryan Oronsky, Tony R. Reid, Arnold Oronsky, Scott Caroen, Corey A. Carter,  and Pedro Cabrales
23439-23442
Abstract  |  PDF  |  HTML  |  Order a Reprint

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma

https://doi.org/10.18632/oncotarget.25215

Alessandro Broccoli, Beatrice Casadei, Alice Morigi, Federico Sottotetti, Manuel Gotti, Michele Spina, Stefano Volpetti, Simone Ferrero, Francesco Spina, Francesco Pisani, Michele Merli, Carlo Visco, Rossella Paolini, Vittorio Ruggero Zilioli, Luca Baldini, Nicola Di Renzo, Patrizia Tosi, Nicola Cascavilla, Stefano Molica, Fiorella Ilariucci, Gian Matteo Rigolin, Francesco D'Alò, Anna Vanazzi, Elisa Santambrogio, Roberto Marasca, Lucia Mastrullo, Claudia Castellino, Giovanni Desabbata, Ilaria Scortechini, Livio Trentin, Lucia Morello, Lisa Argnani,  and Pier Luigi Zinzani
23443-23450
Abstract  |  PDF  |  HTML  |  Order a Reprint

Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells

Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells

https://doi.org/10.18632/oncotarget.25217

Takanori Hayashi, Masahiro Hikichi, Jun Yukitake, Toru Wakatsuki, Eiji Nishio, Toshiaki Utsumi,  and Nobuhiro Harada
23451-23461
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target

Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target

https://doi.org/10.18632/oncotarget.25231

Danielle Brooks, Alexandra Zimmer, Lalage Wakefield, L. Tiffany Lyle, Simone Difilippantonio, Fabio C. Tucci, Stephane Illiano, Christina M. Annunziata,  and Patricia S. Steeg
23462-23481
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer

Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer

https://doi.org/10.18632/oncotarget.25235

Ari J. Rosenberg, Derek A. Wainwright, Alfred Rademaker, Carlos Galvez, Matthew Genet, Lijie Zhai, Kristen L. Lauing, Mary F. Mulcahy, John P. Hayes, David D. Odell, Craig Horbinski, Srinadh Komanduri, Marie-Pier Tetreault, Kwang-Youn A. Kim,  and Victoria M. Villaflor
23482-23493
Abstract  |  PDF  |  HTML  |  Order a Reprint

Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors

Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors

https://doi.org/10.18632/oncotarget.25236

Rashmi Kumari, Martin R. Silic, Yava L. Jones-Hall, Alexandra Nin-Velez, Jer-Yen Yang, Suresh K. Mittal,  and GuangJun Zhang
23494-23504
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells

The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells

https://doi.org/10.18632/oncotarget.25239

Loredana Zocchi, Stephanie C. Wu, Jie Wu, Ken L. Hayama,  and Claudia A. Benavente
23505-23518
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Breast cancer stem cell-like cells generated during TGFβ-induced EMT are radioresistant

Breast cancer stem cell-like cells generated during TGFβ-induced EMT are radioresistant

https://doi.org/10.18632/oncotarget.25240

Julie Konge, François Leteurtre, Maud Goislard, Denis Biard, Sandrine Morel-Altmeyer, Aurélie Vaurijoux, Gaetan Gruel, Sylvie Chevillard,  and Jérôme Lebeau
23519-23531
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model

Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model

https://doi.org/10.18632/oncotarget.25247

Ninh B. Doan, Ha S. Nguyen, Hisham S. Alhajala, Basem Jaber, Mona M. Al-Gizawiy, Eun-Young Erin Ahn, Wade M. Mueller, Christopher R. Chitambar, Shama P. Mirza,  and Kathleen M. Schmainda
23532-23542
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells

Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells

https://doi.org/10.18632/oncotarget.25261

Stefano Volinia, Valeria Bertagnolo, Silvia Grassilli, Federica Brugnoli, Marco Manfrini, Marco Galasso, Cristian Scatena, Chiara Maria Mazzanti, Francesca Lessi, Giuseppe Naccarato, Adelaide Caligo, Enzo Bianchini, Quirino Piubello, Enrico Orvieto, Massimo Rugge, Cristina Natali, Domenico Reale, Andrea Vecchione, Sarah Warner, Carlo Maria Croce,  and Silvano Capitani
23543-23553
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Highly expressed placental miRNAs control key biological processes in human cancer cell lines

Highly expressed placental miRNAs control key biological processes in human cancer cell lines

https://doi.org/10.18632/oncotarget.25264

Daniel Onofre Vidal, Anelisa Ramão, Daniel Guariz Pinheiro, Bruna Rodrigues Muys, Julio Cesar Cetrulo Lorenzi, Cleidson de Pádua Alves, Dalila Luciola Zanette, Greice Andreotti de Molfetta, Geraldo Duarte,  and Wilson Araújo Silva Jr
23554-23563
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial

Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial

https://doi.org/10.18632/oncotarget.25276

Juliana Noguti, Alfred A. Chan, Bradley Bandera, Colin J. Brislawn, Mladjan Protic, Myung S. Sim, Janet K. Jansson, Anton J. Bilchik,  and Delphine J. Lee
23564-23576
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

miRNA122a regulation of gene therapy vectors targeting hepatocellular cancer stem cells

miRNA122a regulation of gene therapy vectors targeting hepatocellular cancer stem cells

https://doi.org/10.18632/oncotarget.25280

Bijay Dhungel, Charmaine A. Ramlogan-Steel, Christopher J. Layton,  and Jason C. Steel
23577-23588
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma

Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma

https://doi.org/10.18632/oncotarget.25283

Aurélie Verney, Alexandra Traverse-Glehen, Evelyne Callet-Bauchu, Laurent Jallades, Jean-Pierre Magaud, Gilles Salles, Laurent Genestier,  and Lucile Baseggio
23589-23598
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Histogram analysis parameters of apparent diffusion coefficient reflect tumor cellularity and proliferation activity in head and neck squamous cell carcinoma

Histogram analysis parameters of apparent diffusion coefficient reflect tumor cellularity and proliferation activity in head and neck squamous cell carcinoma

https://doi.org/10.18632/oncotarget.25284

Alexey Surov, Hans Jonas Meyer, Karsten Winter, Cindy Richter,  and Anna-Kathrin Hoehn
23599-23607
Abstract  |  PDF  |  HTML  |  Order a Reprint

The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy—a single center experience

The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy—a single center experience

https://doi.org/10.18632/oncotarget.25286

Alexandre Arsene-Henry, Jean-Philippe Foy, Magalie Robilliard, Hao-Ping Xu, Louis Bazire, Dominique Peurien, Philip Poortmans, Alain Fourquet,  and Youlia M. Kirova
23608-23619
Abstract  |  PDF  |  HTML  |  Order a Reprint

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival

https://doi.org/10.18632/oncotarget.25306

Colm Keane, Joshua Tobin, Dipti Talaulikar, Michael Green, Pauline Crooks, Sanjiv Jain,  and Maher Gandhi
23620-23627
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac

Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac

https://doi.org/10.18632/oncotarget.25310

Yoko Goto, Ryo Ashida, Akira Nakamura, Satoshi Itasaka, Keiko Shibuya, Mami Akimoto, Nobutaka Mukumoto, Shigemi Matsumoto, Masashi Kanai, Hiroyoshi Isoda, Toshihiko Masui, Yuzo Kodama, Mitsuhiro Nakamura, Kyoichi Takaori, Takashi Mizowaki,  and Masahiro Hiraoka
23628-23635
Abstract  |  PDF  |  HTML  |  Order a Reprint

Changes of signal transductivity and robustness of gene regulatory network in the carcinogenesis of leukemic subtypes via microarray sample data

Changes of signal transductivity and robustness of gene regulatory network in the carcinogenesis of leukemic subtypes via microarray sample data

https://doi.org/10.18632/oncotarget.25318

Cheng-Wei Li, Tzu-Ying Lai,  and Bor-Sen Chen
23636-23660
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study

Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study

https://doi.org/10.18632/oncotarget.25320

Pierre-Jean Lamy, Brigitte Trétarre, Xavier Rebillard, Marie Sanchez, Sylvie Cénée,  and Florence Ménégaux
23661-23669
Abstract  |  PDF  |  HTML  |  Order a Reprint

Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma

Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma

https://doi.org/10.18632/oncotarget.25330

Michael J. Hamilton, Thomas Girke,  and Ernest Martinez
23670-23680
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide

https://doi.org/10.18632/oncotarget.25348

Kei Miyakawa, Satoko Matsunaga, Yutaro Yamaoka, Mina Dairaku, Kento Fukano, Hirokazu Kimura, Tomoyuki Chimuro, Hironori Nishitsuji, Koichi Watashi, Kunitada Shimotohno, Takaji Wakita,  and Akihide Ryo
23681-23694
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Meta-Analysis

Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis

Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis

https://doi.org/10.18632/oncotarget.24923

Zhihui Zhang, Haibiao Xie, Daqiang Liang, Lanbing Huang, Feiguo Liang, Qiang Qi,  and Xinjian Yang
23695-23703
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials

Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials

https://doi.org/10.18632/oncotarget.25281

Chintan Shah, Rohit Bishnoi, Yu Wang, Fei Zou, Harini Bejjanki, Samip Master,  and Jan S. Moreb
23704-23717
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis

Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis

https://doi.org/10.18632/oncotarget.23891

Linghui Deng, Shi Qiu, Yan Yang, Lu Wang, Yuxiao Li, Jing Lin, Qiang Wei, Lu Yang, Deren Wang,  and Ming Liu
23718-23728
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clinical Research Papers

Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study

Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study

https://doi.org/10.18632/oncotarget.25263

Yutaka Fujiwara, Masayuki Takeda, Noboru Yamamoto, Kazuhiko Nakagawa, Kaname Nosaki, Ryo Toyozawa, Chihiro Abe, Ryota Shiga, Kenji Nakamaru,  and Takashi Seto
23729-23737
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Optimal hydration volume among high-risk patients with advanced congestive heart failure undergoing coronary angiography

Optimal hydration volume among high-risk patients with advanced congestive heart failure undergoing coronary angiography

https://doi.org/10.18632/oncotarget.25315

Shi-Qun Chen, Yong Liu, Wei Jie Bei, Ying Wang, Chong-Yang Duan, Deng-Xuan Wu, Kun Wang, Ping Yan Chen, Ji-Yan Chen, Ning Tan,  and Li-Wen Li
23738-23748
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study

Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study

https://doi.org/10.18632/oncotarget.25255

Sheng-Kai Liang, Meng-Rui Lee, Wei-Yu Liao, Chao-Chi Ho, Jen-Chung Ko,  and Jin-Yuan Shih
23749-23760
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Reviews

Stromal cells in breast cancer as a potential therapeutic target

Stromal cells in breast cancer as a potential therapeutic target

https://doi.org/10.18632/oncotarget.25245

Samantha S. Dykes, Veronica S. Hughes, Jennifer M. Wiggins, Henrietta O. Fasanya, Mai Tanaka,  and Dietmar Siemann
23761-23779
Abstract  |  PDF  |  HTML  |  Order a Reprint

p53 and metabolism: from mechanism to therapeutics

p53 and metabolism: from mechanism to therapeutics

https://doi.org/10.18632/oncotarget.25267

Fernando M. Simabuco, Mirian G. Morale, Isadora C.B. Pavan, Ana P. Morelli, Fernando R. Silva,  and Rodrigo E. Tamura
23780-23823
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Oxidative stress in female cancers

Oxidative stress in female cancers

https://doi.org/10.18632/oncotarget.25323

Gloria M. Calaf, Ulises Urzua, Lara Termini,  and Francisco Aguayo
23824-23842
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression

Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression

https://doi.org/10.18632/oncotarget.25377

Jian Ma, Yanxin Fan, Tingting Feng, Fangjun Chen, Zhipeng Xu, Suqing Li, Qingfeng Lin, Xiaoting He, Weihong Shi, Yang Liu, Zhihua Liu, Bin Zhu,  and Xiufeng Cao
23843-23843
Correction  |  PDF

Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients

Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients

https://doi.org/10.18632/oncotarget.25378

Shun-Ichiro Kageyama, Keiji Nihei, Katsuyuki Karasawa, Takeshi Sawada, Fumiaki Koizumi, Shigeo Yamaguchi, Shunsuke Kato, Hidehiro Hojo, Atsushi Motegi, Katsuya Tsuchihara,  and Tetsuo Akimoto
23844-23844
Correction  |  PDF

Retraction

Retraction: PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation

Retraction: PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation

https://doi.org/10.18632/oncotarget.25033

Qiang Ma, Xiuxiu Wu, Jing Wu, Huanwen Wu, Ying Xiao, Lili Wang, Zhiyong Liang,  and Tonghua Liu
23845-23845
Retraction  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC